🔎 Trials Near Me

Почетна › Кронова болест › Misuri › St. Louis

Kliničke studije za Кронова болест u gradu St. Louis, MO

19 studija za Кронова болест traži učesnike na lokacijama u gradu St. Louis i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Тражи се учесникФаза 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • и још 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03816345

A Study of SL-325 in Crohn's Disease Patients

Тражи се учесникФаза 2
  • Clinical Trial Site, St Louis
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT07753850

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Тражи се учесникФаза 3
  • Washington University School of Medicine ( Site 5058), St Louis
Узраст од 16 до 80 · Оба пола · Ажурирано 10. 11. 2026. · NCT06430801

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Тражи се учесникФаза 2
  • KAD Clinical Research, St Louis
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07483073

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Тражи се учесникФаза 3
  • Washington University School of Medicine, St Louis
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Тражи се учесникФаза 2
  • SSM Health DePaul Hospital- St. Louis, Bridgeton · 15 ми удаљено
Узраст од 18 до 85 · Оба пола · Ажурирано 4. 11. 2026. · NCT06226883

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Тражи се учесникФаза 2
  • KAD Clinical Research, St Louis
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07483099

A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease

Тражи се учесникФаза 2
  • Investigational Site Number: 8400013, St Louis
Узраст од 18 до 75 · Оба пола · Ажурирано 2. 11. 2026. · NCT06958536

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Тражи се учесникФаза 4
  • SSM Health Medical Group, Bridgeton · 15 ми удаљено
Узраст од 18 до 80 · Оба пола · Ажурирано 28. 10. 2026. · NCT06581328

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Тражи се учесникФаза 2
  • Specialists In Gastroenterology /ID# 283939, St Louis
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07697456

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Тражи се учесникФаза 3
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
Узраст од 16 до 80 · Оба пола · Ажурирано 21. 10. 2026. · NCT07184944

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Тражи се учесникФаза 3
  • Washington University School of Medicine-Site Number: 8400075, St Louis
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
Узраст од 16 до 80 · Оба пола · Ажурирано 21. 10. 2026. · NCT07184931

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Тражи се учесникФаза 3
  • Washington University School of Medicine, St Louis
Узраст од 2 до 19 · Оба пола · Ажурирано 7. 10. 2026. · NCT04844606

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Тражи се учесникФаза 2
  • Washington University /ID# 266938, St Louis
Узраст од 18 до 75 · Оба пола · Ажурирано 25. 9. 2026. · NCT06548542

DB-3Q for the Treatment of Medically Refractory Crohn's Disease

Тражи се учесникФаза 2
  • Washington University, St. Louis, St Louis
Узраст од 18 до 75 · Оба пола · Ажурирано 1. 9. 2026. · NCT07625293

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

Тражи се учесникФаза 2
  • Washington University School of Medicine, St Louis
Узраст од 18 до 80 · Оба пола · Ажурирано 5. 6. 2026. · NCT06976853

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Тражи се учесникФаза 2
  • Mirador Therapeutics Selected Site, Bridgeton · 15 ми удаљено
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 3. 2026. · NCT07113522

Treatment of Moderate to Severe Refractory Crohn's Disease

Тражи се учесникФаза 1/2
  • Washington University in St. Louis, St Louis
Узраст од 18 до 65 · Оба пола · Ажурирано 10. 12. 2025. · NCT06721962

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

Тражи се учесникОпсервациона студија
  • Washington University in St Louis School of Medicine, St Louis
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2025. · NCT06670638

Studije za Кронова болест u drugim gradovima

Ostale studije u gradu St. Louis

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.